- Corporate Officers - G
- Geraghty James A
Insider Trading History of Geraghty James A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Geraghty James A since 2005.
This trader's CIK number is 1239746.
At the time of last reporting, Geraghty James A was the Director of Pieris Pharmaceuticals, Inc.. (stock ticker symbol PIRS).
Also see all insider trading activities at Pieris Pharmaceuticals, Inc..
Note that in the past
GERAGHTY JAMES A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fulcrum Therapeutics, Inc. (FULC) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | FULC | 10,000 | $91,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genzyme Corp (GENZ) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | GENZ | 0 | $0 | 0 | $0 | 9,750 | $0 |
| 2010 | GENZ | 0 | $0 | 3,329 | $154,989 | 5,000 | $0 |
| 2009 | GENZ | 0 | $0 | 36,875 | $1,920,081 | 36,875 | $1,199,175 |
Yearly summary of insider trading at Gtc Biotherapeutics Inc (GTCB) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | GTCB | 10,000 | $8,690 | 0 | $0 | 0 | $0 |
| 2006 | GTCB | 2,621 | $3,250 | 0 | $0 | 0 | $0 |
| 2005 | GTCB | 11,000 | $17,534 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aceragen, Inc. (IDRA) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | IDRA | 10,000 | $55,800 | 0 | $0 | 0 | $0 |
| 2014 | IDRA | 10,000 | $26,500 | 0 | $0 | 0 | $0 |
| 2013 | IDRA | 400,000 | $747,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Juniper Pharmaceuticals Inc (JNP) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | JNP | 2,000 | $9,638 | 0 | $0 | 0 | $0 |
| 2016 | JNP | 9,000 | $53,616 | 0 | $0 | 0 | $0 |
| 2015 | JNP | 40,550 | $391,729 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pieris Pharmaceuticals, Inc. (PIRS) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | PIRS | 1 | $1 | 0 | $0 | 0 | $0 |
| 2018 | PIRS | 10,000 | $57,500 | 0 | $0 | 0 | $0 |
| 2017 | PIRS | 10,000 | $48,200 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Voyager Therapeutics, Inc. (VYGR) by Geraghty James A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | VYGR | 6,000 | $113,099 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Geraghty James A:
1. Fulcrum Therapeutics, Inc. (FULC)
2. Genzyme Corp (GENZ)
3. Gtc Biotherapeutics Inc (GTCB)
4. Aceragen, Inc. (IDRA)
5. Juniper Pharmaceuticals Inc (JNP)
6. Pieris Pharmaceuticals, Inc. (PIRS)
7. Voyager Therapeutics, Inc. (VYGR)
Table 1. Insider trading of Fulcrum Therapeutics, Inc. (FULC) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-28 | FULC | Buy | 10,000 | 9.16 | 91,600 |
Table 2. Insider trading of Genzyme Corp (GENZ) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-04-04 | GENZ | Option Ex | 9,750 | .00 | 0 |
| 2010-06-11 | GENZ | Sale | 1,000 | 48.81 | 48,810 |
| 2010-05-25 | GENZ | Sale | 2,329 | 45.59 | 106,179 |
| 2010-05-24 | GENZ | Option Ex | 5,000 | .00 | 0 |
| 2009-11-06 | GENZ | Sale | 36,875 | 52.07 | 1,920,081 |
| 2009-11-06 | GENZ | Option Ex | 36,875 | 32.52 | 1,199,175 |
Table 3. Insider trading of Gtc Biotherapeutics Inc (GTCB) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-12-14 | GTCB | Buy | 10,000 | .87 | 8,690 |
| 2006-09-29 | GTCB | Buy | 2,621 | 1.24 | 3,250 |
| 2005-11-11 | GTCB | Buy | 3,000 | 1.61 | 4,824 |
| 2005-05-16 | GTCB | Buy | 3,000 | 1.32 | 3,960 |
| 2005-03-14 | GTCB | Buy | 5,000 | 1.75 | 8,750 |
Table 4. Insider trading of Aceragen, Inc. (IDRA) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-08-07 | IDRA | Buy | 10,000 | 5.58 | 55,800 |
| 2014-05-27 | IDRA | Buy | 10,000 | 2.65 | 26,500 |
| 2013-12-06 | IDRA | Buy | 40,000 | 2.72 | 108,800 |
| 2013-09-16 | IDRA | Buy | 60,000 | 1.90 | 114,000 |
| 2013-08-19 | IDRA | Buy | 300,000 | 1.75 | 525,000 |
Table 5. Insider trading of Juniper Pharmaceuticals Inc (JNP) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-03-17 | JNP | Buy | 2,000 | 4.82 | 9,638 |
| 2016-09-13 | JNP | Buy | 2,000 | 5.96 | 11,930 |
| 2016-08-23 | JNP | Buy | 2,937 | 6.03 | 17,715 |
| 2016-08-22 | JNP | Buy | 4,063 | 5.90 | 23,971 |
| 2015-11-17 | JNP | Buy | 8,000 | 11.75 | 94,000 |
| 2015-08-06 | JNP | Buy | 12,000 | 10.46 | 125,520 |
| 2015-06-01 | JNP | Buy | 20,550 | 8.38 | 172,209 |
Table 6. Insider trading of Pieris Pharmaceuticals, Inc. (PIRS) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-07 | PIRS | Buy | 1 | 1.00 | 1 |
| 2018-05-15 | PIRS | Buy | 10,000 | 5.75 | 57,500 |
| 2017-08-17 | PIRS | Buy | 10,000 | 4.82 | 48,200 |
Table 7. Insider trading of Voyager Therapeutics, Inc. (VYGR) by Geraghty James A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-09-10 | VYGR | Buy | 3,000 | 19.39 | 58,170 |
| 2018-08-17 | VYGR | Buy | 3,000 | 18.31 | 54,929 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Geraghty James A
(Director of Pieris Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.